These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
659 related articles for article (PubMed ID: 36002086)
1. Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB to alleviate LPS-induced ALI. Cai J; Wang YL; Sheng XD; Zhang L; Lv X J Ethnopharmacol; 2022 Nov; 298():115661. PubMed ID: 36002086 [TBL] [Abstract][Full Text] [Related]
2. 23-O-acetylshengmanol-3-O-α-L-arabinoside alleviates lipopolysaccharide-induced acute lung injury through inhibiting IκB/NF-κB and MAPK/AP-1 signaling pathways. Chen C; Li L; Liu X; Zhang D; Liu Y; Li Y J Ethnopharmacol; 2023 Jan; 300():115725. PubMed ID: 36115602 [TBL] [Abstract][Full Text] [Related]
3. Jinhua Qinggan granules attenuates acute lung injury by promotion of neutrophil apoptosis and inhibition of TLR4/MyD88/NF-κB pathway. Zhu Y; Han Q; Wang L; Wang B; Chen J; Cai B; Wu C; Zhu X; Liu F; Han D; Dong H; Jia Y; Liu Y J Ethnopharmacol; 2023 Jan; 301():115763. PubMed ID: 36183949 [TBL] [Abstract][Full Text] [Related]
4. Syringic acid attenuates acute lung injury by modulating macrophage polarization in LPS-induced mice. Wang WT; Zhang YY; Li ZR; Li JM; Deng HS; Li YY; Yang HY; Lau CC; Yao YJ; Pan HD; Liu L; Xie Y; Zhou H Phytomedicine; 2024 Jul; 129():155591. PubMed ID: 38692075 [TBL] [Abstract][Full Text] [Related]
5. Shufeng Jiedu capsules protect rats against LPS-induced acute lung injury via activating NRF2-associated antioxidant pathway. Liao Q; Chen W; Tong Z; Xue M; Gu T; Yuan Y; Song Z; Tao Z Histol Histopathol; 2021 Mar; 36(3):317-324. PubMed ID: 33346364 [TBL] [Abstract][Full Text] [Related]
6. Asiaticoside alleviates lipopolysaccharide-induced acute lung injury by blocking Sema4D/CD72 and inhibiting mitochondrial dysfunction in RAW264.7 cell and mice. Zhang J; Zhao H; Wang F; Zhou J; Li M; Li H; Ren M; Wang L; Ren Q; Zhong X; Jiang X; Zhang Z Naunyn Schmiedebergs Arch Pharmacol; 2024 Oct; 397(10):7573-7587. PubMed ID: 38664244 [TBL] [Abstract][Full Text] [Related]
7. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway. Zhong R; Xia T; Wang Y; Ding Z; Li W; Chen Y; Peng M; Li C; Zhang H; Shu Z J Ethnopharmacol; 2022 Feb; 284():114777. PubMed ID: 34737012 [TBL] [Abstract][Full Text] [Related]
8. [miR-155-5p alleviates lipopolysaccharide-induced inflammatory damage of human SH-SY5Y neuroblastoma cells by down-regulating SOCS1]. Zhou H; Zhou L; Zhang C; Zhou L; Han Y Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Mar; 39(3):220-229. PubMed ID: 36946346 [TBL] [Abstract][Full Text] [Related]
10. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition. Yang S; Yu Z; Wang L; Yuan T; Wang X; Zhang X; Wang J; Lv Y; Du G J Ethnopharmacol; 2017 Mar; 200():147-155. PubMed ID: 28192201 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway. Ju M; Liu B; He H; Gu Z; Liu Y; Su Y; Zhu D; Cang J; Luo Z Cell Cycle; 2018; 17(16):2001-2018. PubMed ID: 30231673 [TBL] [Abstract][Full Text] [Related]
12. Ma Q; Wang K; Yang Q; Ping S; Zhao W; Shou Q; Zhou W; Chen M Mediators Inflamm; 2016; 2016():7934049. PubMed ID: 27890971 [No Abstract] [Full Text] [Related]
13. Therapeutic Mechanistic Studies of ShuFengJieDu Capsule in an Acute Lung Injury Animal Model Using Quantitative Proteomics Technology. Tao Z; Meng X; Han YQ; Xue MM; Wu S; Wu P; Yuan Y; Zhu Q; Zhang TJ; Wong CCL J Proteome Res; 2017 Nov; 16(11):4009-4019. PubMed ID: 28880561 [TBL] [Abstract][Full Text] [Related]
14. Shiwei Qingwen decoction regulates TLR4/NF-κB signaling pathway and NLRP3 inflammasome to reduce inflammatory response in lipopolysaccharide-induced acute lung injury. Zhang Q; Yang C; Ma S; Guo S; Hu X; Zhou Z; Liu Y; Zhang X; Jiang R; Zhang Z; Wen L J Ethnopharmacol; 2023 Sep; 313():116615. PubMed ID: 37164255 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of PKR ameliorates lipopolysaccharide-induced acute lung injury by suppressing NF-κB pathway in mice. Li Y; Xiao J; Tan Y; Wang J; Zhang Y; Deng X; Luo Y Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):165-172. PubMed ID: 28511573 [TBL] [Abstract][Full Text] [Related]
16. Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury Han S; Yuan R; Cui Y; He J; Wang QQ; Zhuo Y; Yang S; Gao H Front Immunol; 2022; 13():846384. PubMed ID: 35281058 [TBL] [Abstract][Full Text] [Related]
17. Urolithin A exerts a protective effect on lipopolysaccharide-induced acute lung injury by regulating HMGB1-mediated MAPK and NF-κB signaling pathways. Jiao P; Wang Y; Ren G; Chu D; Li Y; Yang Y; Sang T Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):5765-5777. PubMed ID: 38319388 [TBL] [Abstract][Full Text] [Related]
18. Overexpressing six-transmembrane protein of prostate 2 (STAMP2) alleviates sepsis-induced acute lung injury probably by hindering M1 macrophage polarization via the NF-κB pathway. Ji L; Shi X; Wang G; Wu H; Hu Z Folia Histochem Cytobiol; 2023; 61(1):34-46. PubMed ID: 36583372 [TBL] [Abstract][Full Text] [Related]
19. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro. Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871 [TBL] [Abstract][Full Text] [Related]
20. Shufeng Jiedu Capsule protect against acute lung injury by suppressing the MAPK/NF-κB pathway. Tao Z; Gao J; Zhang G; Xue M; Yang W; Tong C; Yuan Y Biosci Trends; 2014 Feb; 8(1):45-51. PubMed ID: 24647112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]